Effect of disease activity at three and six months on long ‐term outcomes in ANCA associated vasculitis

ConclusionsThis study suggests that disease status at three and six months may predict the risk of long ‐term mortality and ESRF in AAV, and that these time points may be valid end‐points for induction trials in AAV. These results need to be validated in a larger dataset.This article is protected by copyright. All rights reserved.

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40776?af=R

Source: Arthritis and Rheumatology - November 12, 2018 Category: Rheumatology Authors: Seerapani Gopaluni, Oliver Flossmann, Mark A. Little, Paul O'Hara, Pirow Bekker, David Jayne, European Vasculitis Society Tags: Full Length Source Type: research